DNIB Unwind, Inc. Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BINDQ and buy or sell other stocks, ETFs, and their options commission-free!

About BINDQ

DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. 

CEO
Andrew J. Hirsch, MBA
CEOAndrew J. Hirsch, MBA
Employees
Employees
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2006
Founded2006
Employees
Employees

BINDQ Key Statistics

Market cap
16.32M
Market cap16.32M
Price-Earnings ratio
-0.39
Price-Earnings ratio-0.39
Dividend yield
Dividend yield
Average volume
3.05M
Average volume3.05M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.24
52 Week high$5.24
52 Week low
$0.35
52 Week low$0.35

Stock Snapshot

As of today, DNIB Unwind, Inc. Common Stock(BINDQ) shares are valued at $0.15. The company's market cap stands at 16.32M, with a P/E ratio of -0.39.

DNIB Unwind, Inc. Common Stock(BINDQ) stock opened on 2026-03-03 at —. The price climbed to — and dipped to —.

DNIB Unwind, Inc. Common Stock(BINDQ) shares are trading with a volume of 0, against a daily average of 3.05M.

In the last year, DNIB Unwind, Inc. Common Stock(BINDQ) shares hit a 52-week high of $5.24 and a 52-week low of $0.35.

In the last year, DNIB Unwind, Inc. Common Stock(BINDQ) shares hit a 52-week high of $5.24 and a 52-week low of $0.35.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.